PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Disease ReportsAspergillosis
MeSH D001228 - aspergillosis
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
D009181:Mycoses
$
Success rate
D001228: 
Aspergillosis
D020953:Neuroaspergillosis
0 Companies
0 Drugs
Success rate
D055732:Pulmonary aspergillosis
0 Companies
0 Drugs
Success rate
Events Timeline
Loading
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
TevaAmphotericin b Amphotericin B  1995-03-31   
Miconazole Miconazole  1992-10-30   
Voriconazole Voriconazole  2012-04-06   
Taro PharmaceuticalMiconazole Miconazole  1997-01-13   
Glenmark PharmaceuticalsVoriconazole Voriconazole  2015-09-02   
MylanCaspofungin Caspofungin  2017-09-29   
Itraconazole Itraconazole  2012-07-20   
Voriconazole Voriconazole  2010-04-22   
Miconazole, White petrolatum Vusion 2028-03-30 2006-02-16   
Mayne GroupItraconazole Tolsura 2023-07-25 2018-12-11   
Johnson & JohnsonMiconazole Monistat  1982-01-01   
Itraconazole Sporanox  1992-09-11   
PerrigoMiconazole Miconazole  1997-03-20   
Cosette Pharmaceuticals Miconazole M-zole  1999-04-16   
Miconazole Miconazole  1993-11-19   
P&L Developments (PLD)Miconazole Miconazole  1996-03-29   
CiplaCaspofungin Caspofungin  2018-07-12   
1
2
3
4
5
6
>
Clinical Trials
Historical Success Rate
Phase 1
100%
1/1
Phase 2
78%
7/9
Phase 3
78%
18/23
Approved: 12Overall Success rate: 61%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Taro Pharmaceutical
Mylan
1
2
3
4
>
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use